Bayer receives positive CHMP opinion for Eylea™ in the EU for treatment of preterm infants with retinopathy of prematurity
Not intended for U.S. and UK Media Berlin, November 11, 2022 – The Committee for Medicinal Products for Human Use ...
Read moreDetails